Advantage: Various modes of pharmacological intervention like posterior subtenon triamcinolone, intravitreal triamcinolone and bevacizumab, have been seen to be useful in macular edema in BRVO. However, use of triamcinolone has risk of cataract and glaucoma development while bevacizumab is an expensive drug. Intravitreal diclofenac has been found to be effective in decreasing diabetic macular edema but has not been used in macular edema...

Read More